David Parrot

CHIEF FINANCIAL OFFICER · SCRIBE THERAPEUTICS, INC. · CIK 0002127908

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

$20.0K

COMPANIES

ACTIVE SINCE

Mar 2026

HOLDINGS NOW

109,426

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for David Parrot. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

SCTX · 109,426 shares · as of Jul 23, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 4 buys / 0 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
SCTX SCRIBE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	109,426	—	—	109,426	Jul 23, 2026	Jul 27, 2026 ↗	View →
SCTX SCRIBE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	109,426	—	—	109,426	Jul 23, 2026	Jul 27, 2026 ↗	View →
SCTX SCRIBE THERAPEUTICS, INC.	PURCHASE Chief Financial Officer	1,333	$15.00	$20.0K	1,333	Jul 23, 2026	Jul 27, 2026 ↗	View →
SCTX SCRIBE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	8,909	—	—	8,909	Mar 13, 2026	Jul 27, 2026 ↗	View →

Other insiders · SCTX

Loading peer insiders…

About this filer

CIK 0002127908

ROLE

Chief Financial Officer

PRIMARY

SCTX

COMPANIES

ACTIVE SINCE

Mar 2026

MARKETPEEL · /INSIDER/0002127908DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.